The Dominican Society of Orthopedics and Traumatology (SDOT) and the pharmaceutical sector reinforce their strategic alliance in favor of the scientific development of orthopedics. This key gathering brings together experts to advance innovative and sustainable bone health treatments.
Key meeting strengthens the strategic alliance
SDOT representatives met with leaders of pharmaceutical industries and providers of osteosynthesis materials. The main goal is to boost research and practical applications in traumatology. This strategic alliance seeks to raise medical standards in the Dominican Republic, where orthopedic conditions affect thousands annually.
Historical context of the collaboration
SDOT, founded decades ago, has driven advances in bone and joint surgeries. Historically, collaborations with the pharmaceutical sector have introduced implants and drugs that reduce recovery times. Data from the Ministry of Public Health indicate that fractures from falls represent 20% of orthopedic consultations in the country.
Benefits of scientific development in orthopedics
- Access to cutting‑edge osteosynthesis materials for precise surgeries.
- Joint research on regenerative therapies for damaged cartilage.
- Ongoing training for specialists, improving clinical outcomes.
Expert opinions and projections
Dr. Rafael Escalante, president of SDOT, emphasized that this strategic alliance ensures accessible innovation. Sector experts agree: 30% of global orthopedic advances come from pharmaceutical companies. In the Dominican Republic, post‑surgical complications are expected to be reduced by 15% in the coming years, according to internal projections.
This initiative responds to a rise in bone pathologies due to population aging. The strategic alliance includes protocols for local clinical trials, aligned with international standards. Professionals highlight its impact on the sustainability of the health system.
The scientific development driven by this union promises to transform Dominican orthopedics. With an emphasis on evidence‑based practice, SDOT and the pharmaceutical sector cement their strategic alliance as a pillar for the country’s medical future, directly benefiting patients with effective and affordable solutions.
